Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Adam, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adam, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2002) 50, 1-5
© 2002 The British Society for Antimicrobial Chemotherapy

Supplement

Global antibiotic resistance in Streptococcus pneumoniae

Dieter Adam*

Kinderklinik der Universität München, Lindwurmstrasse 4, 80337 Munich, Germany

Abstract

The last two decades of the 20th century were marked by an increasing resistance rate among several bacteria. Threat of resistance is present in Staphylococcus spp., Enterococcus spp., Pseudomonas spp. and Enterobacteriaceae, which are the major pathogens in nosocomial infections. In the community, too, increasing resistance can be observed and is attributed mainly (but not exclusively) to Streptococcus pneumoniae and Haemophilus influenzae. To scrutinize this trend, resistance surveillance in the community was established about 10 years ago. One of the multinational, longitudinal surveillance programmes in place is the Alexander Project, which was established in 1992 to monitor the susceptibility of the major community-acquired lower respiratory tract pathogens to a range of antibacterial drugs. The Alexander Project has revealed a tendency towards increasing resistance of S. pneumoniae to penicillin and macrolide therapy. Within Europe, the prevalence of penicillin resistance among S. pneumoniae isolates is particularly high in France and Spain. Macrolide resistance in S. pneumoniae is also a growing problem in European countries such as France, Spain, Belgium and Italy, where the extent of macrolide resistance in S. pneumoniae now exceeds that of penicillin resistance.

Footnotes

* Tel: +49-89-6424-9595; Fax: +49-89-6424-9597; E-mail d.adam{at}kk-i.med.uni-muenchen.de


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
K. A. Nichol, H. J. Adam, J. A. Karlowsky, G. G. Zhanel, and D. J. Hoban
Increasing Genetic Relatedness of Ciprofloxacin-Resistant Streptococcus pneumoniae Isolated in Canada from 1997 to 2005
Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1190 - 1194.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Morand and K. Muhlemann
Heteroresistance to penicillin in Streptococcus pneumoniae
PNAS, August 28, 2007; 104(35): 14098 - 14103.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
X. Valles, A. Marcos, M. Pinart, R. Piner, F. Marco, J. M. Mensa, and A. Torres
Hospitalized Community-Acquired Pneumonia Due to Streptococcus pneumoniae: Has Resistance to Antibiotics Decreased?
Chest, September 1, 2006; 130(3): 800 - 806.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. Dias, D. Louro, the Antimicrobial Resistance Surveillance Program, and M. Canica
Antimicrobial Susceptibility of Invasive Streptococcus pneumoniae Isolates in Portugal over an 11-Year Period.
Antimicrob. Agents Chemother., June 1, 2006; 50(6): 2098 - 2105.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
A. Kronenberg, P. Zucs, S. Droz, and K. Muhlemann
Distribution and Invasiveness of Streptococcus pneumoniae Serotypes in Switzerland, a Country with Low Antibiotic Selection Pressure, from 2001 to 2004.
J. Clin. Microbiol., June 1, 2006; 44(6): 2032 - 2038.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
M. H. Samore, M. Lipsitch, S. C. Alder, B. Haddadin, G. Stoddard, J. Williamson, K. Sebastian, K. Carroll, O. Ergonul, Y. Carmeli, et al.
Mechanisms by Which Antibiotics Promote Dissemination of Resistant Pneumococci in Human Populations
Am. J. Epidemiol., January 15, 2006; 163(2): 160 - 170.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
I. Morrissey, M. Robbins, L. Viljoen, and D. F. J. Brown
Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods
J. Antimicrob. Chemother., February 1, 2005; 55(2): 200 - 208.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J.-H. Song, H.-H. Chang, J. Y. Suh, K. S. Ko, S.-I. Jung, W. S. Oh, K. R. Peck, N. Y. Lee, Y. Yang, A. Chongthaleong, et al.
Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)
J. Antimicrob. Chemother., March 1, 2004; 53(3): 457 - 463.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
I. Morrissey and G. Tillotson
Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae
J. Antimicrob. Chemother., February 1, 2004; 53(2): 144 - 148.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.